CHISON MEDICAL's three major shareholders' reduction plan has expired, and none of them have implemented the reduction

Recently, CHISON MEDICAL announced the expiration of the shareholder reduction plan and the results of the share reduction. Previously, shareholders Xiangding Investment, Shanghai Yude, and Xiangpeng Investment planned to reduce their holdings by no more than 1.05%, 0.37%, and 0.30% of the company's shares, respectively. As of the expiration date of the reduction period on August 21, 2025, none of the three shareholders had reduced their holdings in the company. Before the reduction, Xiangding Investment, Shanghai Yude, and Xiangpeng Investment held 4,704,000 shares, 1,679,956 shares, and 1,344,000 shares, accounting for 4.20%, 1.50%, and 1.20% of the total share capital, respectively. The actual reduction situation is consistent with the previously disclosed reduction plan, and the reduction plan was not terminated early